This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Stocks to Watch: Inhibitex, Alcoa (Update 1)

NEW YORK ( TheStreet) -- Bristol-Myers Squibb (BMY) plans to acquire Inhibitex (INHX) for $2.5 billion.

Bristol-Myers' all-cash tender offer values Inhibitex at $26 a share, or more than two-and-a-half times the company's closing stock price on Friday of $9.87.

For all that cash, Bristol-Myers gains control of Inhibitex's INX-189, a pill in phase II studies which has the potential to become a component in the first all-oral therapies against hepatitis C.

Bristol-Myers shares were gaining 1.6% to $34.76, while Inhibitex shares were soaring 150% to $24.65 in premarket trading on Monday.


Achillion (ACHN), in other hepatitis C drug news, said preliminary results for its ACH-1625 treatment for genotype 1 treatment-naive hepatitis C showed complete early virologic response after 12 weeks.

The shares were climbing 15% to $9.08 in premarket trading.


Alcoa (AA - Get Report) posts results after the closing bell Monday, marking the unofficial start to the earnings season.

The aluminum maker last week said its global smelting capacity will be reduced by 12% after the closure of certain plants. Alcoa said it would record fourth-quarter restructuring charges of $155 million to $165 million.

Analysts' expectations on Alcoa's results vary from a loss of 5 cents a share to a profit of 1 cent.

Shares were up 0.9% to $9.24 in premarket trading.


Lions Gate Entertainment (LGF - Get Report) is close to buying Summit Entertainment, the maker of the Twilight series of vampire movies.

Lions Gate plans to spend $400 million in cash and stock on the movie studio, according to a report by The Associated Press that cited two anonymous sources familiar with the deal.


Netflix (NFLX - Get Report), which advanced 25% in the first week of trading in 2012, will launch its streaming video service in the U.K. and Ireland on Monday.

The video-streaming service will offer a one-month free trial in order to compete in a market currently dominated by Amazon's (AMZN - Get Report) Lovefilm and British Sky Broadcasting Group. Netflix has already said it will lose money in 2012 because of the expansion across the Atlantic.

In response to Netflix's plans to offer unlimited video content for 5.99 pounds a month, Lovefilm announced Monday plans to offer unlimited streaming service for an introductory price of 4.99 pounds a month.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ACHN $12.14 0.00%
AA $14.79 0.00%
AMZN $380.16 0.00%
BMY $60.92 0.00%
F $16.34 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs